SIGN IN
Pharmacists - AI Training - Columbus, USA jobs in United States
cer-icon
Apply on Employer Site
company-logo

Prolific · 2 months ago

Pharmacists - AI Training - Columbus, USA

Prolific is a company focused on building the largest pool of quality human data for AI development. They are seeking Licensed Pharmacists to train and evaluate AI models, ensuring that these systems are guided by pharmaceutical expertise.
Artificial Intelligence (AI)Big DataMarketingCrowdsourcingData Collection and LabelingMachine LearningMarket ResearchProduct Research

Responsibilities

Evaluating Accuracy: Reviewing AI-generated responses to pharmaceutical scenarios and rating them for accuracy, safety, and clinical reasoning
Comparative Analysis: Comparing multiple model answers and selecting/justifying the best response based on current pharmacy standards
Content Creation: Writing improved exemplars, rationales, or structured feedback to help models learn where they fall short in medication counseling or pharmacology

Qualification

Pharmacy licenseBoard certificationClinical pharmacy experienceRetail pharmacy experienceHospital pharmacy experienceDrug interaction evaluationDosing evaluationTherapeutic reasoning

Required

Current license/registration in good standing (e.g., PharmD, RPh, or equivalent) and board certification where applicable
Recent experience in retail, clinical, or hospital pharmacy, with comfort in evaluating drug interactions, dosing, and therapeutic reasoning
Strong attention to detail and the ability to focus on complex medical data for up to one hour
A reliable, fast internet connection, a computer, and a PayPal account to receive payments
Willingness to self-declare earnings (participants are considered self-employed)
Willingness to complete a short skills/eligibility screener to join our Domain Expert pool

Benefits

Competitive pay rates
Flexible hours
The ability to work from home

Company

Prolific

twitterlinkedincrunchbase
company-logo
Building the most advanced global infrastructure for People Science.

Funding

Current Stage
Growth Stage
Total Funding
$33.54M
Key Investors
Oxford Science Enterprises,PartechAltaIR Capital,Pioneer Fund
2023-07-11Series A· $32.34M
2019-12-04Seed· $1.2M

Leadership Team

leader-logo
Phelim Bradley
CEO
linkedin
Company data provided by crunchbase